No revision in stent prices till February, says National Pharmaceutical Pricing Authority

Drug price regulator will revisit the prices of coronary stents in February 2018 taking into account all the issues, says National Pharmaceutical Pricing Authority
Source: Livemint.com (http://www.livemint.com/rss/industry)